Study Type
Observational
completed
The overarching goal of the MIPAD study was to reduce the morbidity and mortality of post-MI patients through improved long-term cardiac medication adherence.
The specific objectives include:
- To assess the impact on long-term cardiac medication adherence following the implementation of a standardized process to increase in discharge prescription length to 90-days with three repeats in post-MI patients as compared to education alone and usual care.
- To assess the cost implications of the prolonged initial discharge prescriptions as compared to usual care.
- To compare clinical outcomes between longer (>60 days) versus shorter prescription durations.
- To collect baseline information to inform a multi-centre interventional study (i.e., simple monthly proportions of 1-year adherence by hospitals in Ontario).
Noah Ivers was Co-PI on the MIPAD study with JD Schwalm.
Study Design
Quasi-experimental, controlled interrupted time series
NO. of Countries
1
NO. of Sites
4
NO. of Participants
8000
Study Period
2017-2019
Sponsor
PHRI
JD Schwalm
Scientist
JD Schwalm
Scientist
JD Schwalm is a Scientist in the Knowledge Translation and Health Systems research program at PHRI, an Associate Professor, Department of Medicine at McMaster University, and an Interventional Cardiologist at Hamilton Health Sciences (HHS) and Niagara Health. Schwalm is also the site lead for Cardiology at the Hamilton General Hospital and the Director of the Centre for Evidence-Based Implementation (www.hhsCEBI.ca), HHS.
Schwalm completed medical school, Internal Medicine residency, and Cardiology and Interventional Cardiology fellowship training at McMaster University, Ontario. He also did further Interventional Training and a Master of Science in Epidemiology, with an interest in Knowledge Translation at the University of Ottawa. He is a fellow of the Royal College of Physicians and Surgeons of Canada, with certification in Internal Medicine and Cardiology.
His research, supported by CIHR, The Ministry of Health (Ontario), HAHSO, WHO, and WHF, focuses on Knowledge Translation/Implementation Sciences as it relates to the field of cardiology at the patient, physician, and health system level. Schwalm has authored more than 95 peer-reviewed publications, including high-impact journals (i.e. The Lancet and BMJ).
Tara McCready
Program Director
Tara McCready
Program Director
Tara McCready, PhD, oversees a variety of collaborative programs at PHRI, and serves as Project Manager for PHRI research studies and registries.
She was recruited to PHRI as a Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN), a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes.
Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Tara holds a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.
Jennifer Cunningham
Project Manager
Jennifer Cunningham
Project Manager
Jennifer Cunningham has more than 20 years’ experience working in research at PHRI. Starting with a few months assisting in research accounting in the then CCC Project Office in 1998, she began her PHRI career with study teams in 2000. Since then, Jennifer has had many roles at PHRI, from data management to her current role in project management; and has worked on and managed multiple studies, from large international cardiovascular, national gastrointestinal, to policy changes and vulnerable/marginalized people studies within our own local community.
